Amgen Inc. (AMGN)

NMS – Real Time Price. Currency in USD

415.58

+1.28 (0.31%)

Market open: Aug 12, 2026, 1:50 PM EDT

414.00

-0.30 (-0.07%)

Previous after-hours: Aug 11, 2026, 7:55 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

36.74B

33.23B

28.01B

26.09B

Cost of goods sold

-10.73B

-11.90B

-7.71B

-6.41B

Gross Profit

26.01B

21.33B

20.30B

19.69B

Operating expenses (excl. COGS)

-15.34B

-13.02B

-11.12B

-10.35B

Operating Income

10.68B

8.31B

9.18B

9.34B

Non-operating income, total

-1.70B

-3.70B

-1.32B

-1.99B

Pretax income

8.98B

4.61B

7.86B

7.35B

Equity in earnings

Taxes

-1.26B

-519M

-1.14B

-794M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

7.71B

4.09B

6.72B

6.55B

Discontinued operations

Net income

7.71B

4.09B

6.72B

6.55B

Dilution adjustment

Preferred dividends

Amgen Inc. (AMGN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Amgen Inc. (AMGN)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Amgen Inc. (AMGN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Amgen Inc. (AMGN)

Income Statement (Annual)

Income Statement (Annual)